AOBO
DEAD

Serial Number

77231567

Owner

AMERICAN ORIENTAL BIOENGINEERING INC

Attorney

David W. Grace

Filing Date

Jul 17, 2007

Add to watchlist:

No watchlists yet
View on USPTO

AOBO Trademark

Serial Number: 77231567

AOBO is a trademark filed by AMERICAN ORIENTAL BIOENGINEERING INC on July 17, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently no longer active.

Owner Contact Info

AMERICAN ORIENTAL BIOENGINEERING INC (10 trademarks)

90 PARK AVENUE, 17TH FLOOR
NEW YORK, NY 10016

Entity Type: 03

Trademark Details

Filing Date

July 17, 2007

Registration Date

Not Registered

Published for Opposition

December 9, 2008

Goods & Services

coffee; herbal coffee substitutes; beverages containing coffee; coffee with additives; tea; sugar free and sugarless sweets; flavoring additives for non-nutritional purposes; cakes; ice cream; condiments, namely, pepper sauce; soybean molasses; cocoa beverages with milk; vinegar; flavor enhancers used in food and beverage products; processed herbs; prepared coffee and coffee-based beverages

Soy protein for use as a food additive; condiments, namely, pepper oil; soybean oil, soybean milk; dried edible algae as a non-medical supplement; milk beverages with high milk content

Pharmaceutical preparations for use in chemotherapy, herbal supplements for the treatment of the digestive system, respiratory system, immune system, circulatory system, reproductive system, nervous system, namely, antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceutical; bismuth preparations for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; anticoagulants; antidepressants; appetite suppressants; pharmaceuticals for the treatment of gout, heart rhythm disorders, allergic rhinitis and asthma, diabetes, gastro-intestinal diseases and hormonal disorders; pharmaceuticals for inhalation for the treatment of pulmonary hypertension; pharmaceuticals for ocular or intraocular surgery; pharmaceuticals for the prevention of osteoporosis; pharmaceuticals for use in dermatology; pharmaceuticals for wounds; pharmaceuticals for use in urology; pharmaceuticals against dry skin caused by pregnancy, chloasma, for hydrating the skin during pregnancy, for pregnancy blemishes, for preventing blemishes during pregnancy; potassium preparations; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; dietary supplement drink mixes; raw medicines, namely, ointments for medical use or medicinal oils, anti-rheumatic oil, coryza oil, essential embrocation; gynecological products, namely, vaginal washes, medicinally treated sanitary towels; medicines used to support the health of the circulatory and female reproductive system, namely, medicines for the treatment of menorrhagia or continuous uterine bleeding, medicines for activating blood circulation, medicines for regulating menstruation, medicines for the treatment of endometritis and pelvic inflammatory disease; traditional Chinese medicines, namely, ointments for medical use or medicinal oils, anti-rheumatic oil, coryza oil, essential embrocation, medicinal teas, ginseng for medicinal use, herbal medicine, for the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system and nervous system; medicated balms; medicinal teas, ginseng for medicinal use; herbal medicine, for the treatment of the digestive system, respiratory system, immune system, circulatory system, female reproductive system, nervous system; herbal medicines; medicinal sweets; dietary supplements; food supplements, herbal supplements, homeopathic supplements, meal replacement and dietary supplement drink mixes, nutraceuticals for use as a dietary supplement; nutritional additives for medical purposes for use in foods for human consumption; nutritional supplements; powdered nutritional supplement drink mix; dietary supplemental drinks; vitamin and mineral supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; vitamin supplements; soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of gynecological disorders; medicinal herbs in dried or preserved form; pharmaceutical preparations for the treatment of colds and fevers; pharmaceutical preparations for the treatment of enuresis; herb teas for medicinal purposes

Beer containing soy peptide; fruit juice; drinking water and mineral spring water; cola drinks; soy-based beverages not being milk substitutes; powders used in the preparation of soft drinks; energy drinks; soft drinks; non-alcoholic beer; beer

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 5, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 5, 2009 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2009 NOAM
PUBLISHED FOR OPPOSITION
Dec 9, 2008 PUBO
NOTICE OF PUBLICATION
Nov 19, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 6, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2008 TROA
NON-FINAL ACTION MAILED
Jul 17, 2008 CNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2008 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2008 CRFA
ASSIGNED TO LIE
Jun 24, 2008 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2008 TROA
NON-FINAL ACTION MAILED
May 30, 2008 CNRT
NON-FINAL ACTION WRITTEN
May 29, 2008 CNRT
ATTORNEY REVIEW COMPLETED
May 29, 2008 ATRV
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2008 TROA
NON-FINAL ACTION MAILED
Nov 13, 2007 CNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2007 CNRT
ASSIGNED TO EXAMINER
Oct 22, 2007 DOCK
NEW APPLICATION ENTERED
Jul 20, 2007 NWAP